10 Best Industrial Disributor Stocks To Own Right Now

Exterran Holdings (NYSE: EXH  ) is expected to report Q1 earnings on May 2. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Exterran Holdings's revenues will grow 21.6% and EPS will turn positive

The average estimate for revenue is $761.9 million. On the bottom line, the average EPS estimate is $0.03.

Revenue details
Last quarter, Exterran Holdings reported revenue of $838.9 million. GAAP reported sales were 22% higher than the prior-year quarter's $689.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.09. GAAP EPS were -$0.09 for Q4 compared to -$1.06 per share for the prior-year quarter.

Top Gas Companies To Buy For 2015: CombiMatrix Corporation(CBMX)

CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the fields of genetic analysis and molecular diagnostics in the United States. The company, through its wholly owned subsidiary, CombiMatrix Diagnostics, operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, and other laboratories in two primary areas, including prenatal and postnatal developmental disorders, and oncology. It offers a suite of developmental disorder array tests on the prenatal and postnatal application of array-comparative genomic hybridization in diagnosing genomic syndromes associated with developmental delays, autism spectrum disorders, dysmorphic features, and/or birth defects. The company also provides DNAarray?Heme Profile test to address various common hematological malignancies, including chronic lymphocytic leukemia; DNAarray?HER2 PRO test for breast cancer; and DNAarray?Tumor Profile test for the analysis of solid tumors, including breast, colon, lung, prostate, and brain tumors. In addition, it focuses on developing a series of drug compounds to address various oncology-related diseases. CombiMatrix Corporation was founded in 1995 and is based in Irvine, California.

Advisors' Opinion:

• [By Wallace Witkowski]

  Also, shares of Combimatrix Corp. (CBMX) rose 7.5% to $2.73 in moderate volume late Friday following a Securities and Exchange Commission filing showing Longwood Capital Partners acquired a 5.1% stake in the microcap molecular diagnostics company.

• [By Bryan Murphy]

  Looking for a couple of long (bullish) trading ideas on a day when the market is dragging pretty much everything lower? There are two names that fit the bill...CombiMatrix Corp. (NASDAQ:CBMX) and Banro Corporation (NYSEMKT:BAA). CBMX is an "almost" small cap stock that deserves a place on your watchlist while we wait for it to do one more thing. Meanwhile, BAA is something worth going ahead and taking a swing on now, not despite the market's tumble, but because of it.

• [By Roberto Pedone]

  One stock that's starting to trend within range of triggering a near-term breakout trade is CombiMatrix (CBMX), which operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of prenatal and postnatal development disorders, and hematology/oncology genomics. This stock hasn't done much over the last three months, with shares up by just 1.4%.

  If you take a look at the chart for CombiMatrix, you'll notice that this stock has been uptrending over the last few weeks, with shares moving higher from its low of $2.14 to its recent high of $2.90 a share. During that move, shares of CBMX have been making mostly higher lows and higher highs, which is bullish technical price action. That uptrend has now pushed shares of CBMX within range of triggering a near-term breakout trade.

  Traders should now look for long-biased trades in CBMX if it manages to break out above some near-term overhead resistance levels at $2.90 to $2.92 a share, and then once it clears its 200-day moving average at $2.96 to more near-term overhead resistance at $3.20 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 823,656 shares. If that breakout triggers soon, then CBMX will set up to re-test or possibly take out its next major overhead resistance levels at $3.70 to $4.44 a share.

  Traders can look to buy CBMX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $2.57 a share or just below more support at $2.20 to $2.14 a share. One can also buy CBMX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

10 Best Industrial Disributor Stocks To Own Right Now: Louisiana-Pacific Corp (LPX)

Louisiana-Pacific Corporation, incorporated on July 20, 1972, is a manufacturer of building products. The Company operates in four segments: North America Oriented Strand Board (OSB); Siding; Engineered Wood Products (EWP), and South America. As of December 31, 2012, the Company owned 21 modern located facilities in the United States and Canada, two facilities in Chile and one facility in Brazil. The Company also operates three facilities through joint ventures, for which it is the provider of product distribution for North America and participate in a joint venture operation that produces cellulose insulation in multiple facilities. The Company�� products are used primarily in new home construction, repair and remodeling, and manufactured housing. In May 2013, Canfor Corp announced that it has completed the sale of its 50% interest in the Peace Valley Oriented Strand Board (OSB) joint venture in Fort St. John, B.C., to Louisiana-Pacific Corp (LP).

OSB

The Company�� OSB segment manufactures and distributes OSB structural panel products. OSB is a smart product made from wood strands arranged in layers and bonded with resin. OSB serves many of the same uses as plywood, including roof decking, sidewall sheathing and floor underlayment. During the year ended December 31, 2012, OSB accounted for approximately 58% of the structural panel consumption in North America.

Siding

The Company�� siding offerings are of two categories: SmartSide siding products and related accessories; and CanExel siding and accessory products. Its SmartSide products consist of a line of wood-based sidings, trim, soffit and fascia. Its CanExel siding and accessory product offerings include a number of pre-finished lap and trim products in a variety of patterns and textures. Additionally, minor amounts of commodity OSB are produced and sold in this segment.

Engineered Wood Products

The Company�� Engineered Wood Products (EWP) segment manufactures! and distributes laminated veneer lumber (LVL), I-Joists, laminated strand lumber (LSL) and other related products. This segment also includes the sale of I-Joist produced by its joint venture with Resolute Forest Products (formerly AbitibiBowater) and LVL sold under a contract manufacturing arrangement.

South America

The Company�� South American segment manufactures and distributes OSB and siding products in South America and certain export markets. This segment also distributes and sells related products to augment the transition to wood frame construction.

Other Products

The Company�� other products category includes its decorative moulding and its joint venture that produces cellulose insulation. Additionally, it other products category includes its remaining timber and timberlands, and other minor products, services and closed operations.

Advisors' Opinion:

• [By Dan Caplinger]

  In Weyerhaeuser's report, watch for the company to discuss any plans for potential buyout activity. With tight supplies, smaller rivals Louisiana-Pacific (NYSE: LPX  ) or Potlatch (NASDAQ: PCH  ) might make good targets for the larger Weyerhaeuser or Plum Creek to look at for expansion. Even though those companies have seen their shares rise dramatically as well, it might be worth paying up in order to secure long-term assets that could produce strong growth for Weyerhaeuser.

10 Best Industrial Disributor Stocks To Own Right Now: Osiris Therapeutics Inc.(OSIR)

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Advisors' Opinion:

• [By Alexander Maxwell]

  One of the companies attempting to develop a better treatment for chronic diabetic foot ulcers is Osiris Therapeutics� (NASDAQ: OSIR  ) . Earlier this month, Osiris shares more than doubled as the company announced positive data for its CDFU drug Grafix. The study results were very impressive to say the least; the study was stopped early due to the overwhelming efficacy exhibited by the treatment. A main highlight is the fact that 62% of Grafix patients had their wound closed at 12 weeks, compared to only 21% of patients using conventional methods. Clearly, the efficacy in this endpoint was overwhelming. Grafix also achieved all of the secondary endpoints for the trial, and more importantly demonstrated a relatively benign safety record.�

• [By Maxx Chatsko]

  Additionally, stem cell therapies have remained elusive as the industry's ultimate Holy Grail. Osiris (NASDAQ: OSIR  ) received Canadian approval for the world's first stem cell drug, Prochymal, for children battling acute graft-versus-host disease, or GvHD, last year. The approval meant more symbolically than to the bottom line, but it definitely put the potential of stem cells front and center for investors.

10 Best Industrial Disributor Stocks To Own Right Now: Cvent Inc (CVT)

Cvent, Inc., incorporated on August 20, 1999, is a cloud-based enterprise event management platform. The Company offers an integrated cloud-based software platform that addresses the lifecycle of events and meetings. It provides solutions for both sides of the events and meetings value chain, which include event and meeting planners, and hotels and venues. Its integrated, cloud-based solution addresses the entire event lifecycle by allowing event and meeting planners to organize, market and manage their meetings, conferences, tradeshows and other events. The Company�� online marketplace connects event planners and venues through its vertical search engine that accesses its database of detailed hotel and venue information. It offers six product categories: event management software, strategic meetings management (SMM) software, mobile event apps, pre- and post-event Web surveys, ticketing software and the Cvent Supplier Network (CSN).

The Company offers planners a platform that addresses the lifecycle of events and meetings, including budgeting, planning, venue sourcing, marketing, management and measurement of meetings. The combination of these solutions creates an integrated platform that allows the Company to generate revenue from both sides of the events and meetings value chain. Through the CSN, the Company has created an online marketplace to connect hotels and venues with enterprise event and meeting planners. The Company�� online marketplace, the Cvent Supplier Network (CSN), connects tens of thousands of event and meeting planners seeking the venue for their event with more than 200,000 venues featured in its database.

The Company�� solutions include online event registration; event marketing; budgeting and project management; event logistics and integrations; measurement and reporting, and training and support. Its event marketing solution provides e-marketing tools that allow planners integrate their event marketing and communication process wit! h registration. The Company�� budgeting and project management includes a project management suite that allows for assignment and tracking of event planning tasks. The Company�� event logistics and integrations solution includes tools for table and seating management, name badge and certificate creation, resource and space allocation, speaker management, appointment scheduling, continuing education credit tracking, onsite registration and check-in functionality. Its measurement and reporting platform measures aspects of the event management process. The Company provides training and support to its event management subscription customers, which is available through phone, e-mail and the Internet during the subscription period.

Advisors' Opinion:

• [By Jon C. Ogg]

  Cvent Inc. (NYSE: CVT) was started as Buy with a $41 price target at Stifel Nicolaus, started as Outperform with a $40 price target at Pacific Crest and started as Buy with a $42 price target at Needham & Company. Shares are up about 1.5% at $36.15

• [By Matt Jarzemsky]

  The deal by the data-analysis software maker follows well-received offerings by software makers Workday Inc.(WDAY) and Cvent Inc.(CVT) last week, suggesting investor interest in cloud computing and ��ig data��analysis remain high. Those deals bucked the broader market�� sluggish tone, with indexes little changed out of the gate this year and many strategists predicting muted returns after 2013�� rally.

10 Best Industrial Disributor Stocks To Own Right Now: Aeon Metals Ltd (AQR)

Aeon Metals Limited is an Australia-based company. Its principal activity is exploration of the Rawbelle tenement for porphyry copper/molybdenum mineralization near Monto, Queensland. The principal project is the Greater Whitewash Polymetallic Project, which consists of four deposits over a strike length of five kilometers and width of one kilometer. Its other projects include Kiwi Carpet, Kildare Project, Juicy Fruit, and Anomaly 7B. As of June 30, 2012, it controlled seven contiguous exploration permits for minerals (EPMs): 14628, 15920, 15921, 15922, 17001, 17702, 17060, which are 100% held by the Company and three contiguous EPMs at Kidare: 14627, 15919, and 18202. During the fiscal year ended June 30, 2012 (fiscal 2012), it drilled 37 holes for 9,112 meters, being7, 440 meters reverse circulation (RC) and 1672 meters of diamond drilling (DD) on Rawbelle tenement. As of June 30, 2012, Kiwi Carpet porphyry copper area has had 20 drill holes which returned grades of copper. Advisors' Opinion:

• [By Marc Chandler]

  3. The flash euro area PMIs, due Thursday, stand out as the most market sensitive economic data from the euro area. Although the sentiment has been running ahead of real sector data, slight positive growth has replaced the recent contraction. Next Wednesday, the ECB is expected to unveil the broad details of the Asset Quality Review (AQR). This is not a stress test. It is a preliminary review of the books of the banks for which it will soon have supervisory responsibilities. Definitions of risk-weighted assets various in the euro area and some uniformity is a necessary condition of a banking union. New stress tests will be conducted next year.

10 Best Industrial Disributor Stocks To Own Right Now: Actelion Ltd (ATLN.VX)

Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease. Furthermore, the Company has a number of compounds various stages of development. The Company operates through a number of worldwide subsidiaries, including Actelion Registration Ltd, which holds marketing authorizations for products marketed in the European Union; Actelion Clinical Research, Inc, engaged in clinical development on behalf of the Company's group; Actelion Re SA, providing insurance solutions for the Company's group and Actelion US Holding Company, engaged in the holding activities of the Company's United States-based units. In September 2013, it acquired Ceptaris Therapeutics, Inc. Advisors' Opinion:

• [By Victor Selva]

  Forest Laboratories has a current ratio of 2.69% which is higher than the ones registered by Endo International Plc (ENDP), Valeant Pharmaceuticals International (VRX) and Cubist Pharmaceuticals Inc. (CBST). For investors looking for a higher ROE, Allergan Inc. (AGN) and Actelion Ltd. (ATLN.VX) are good options.

10 Best Industrial Disributor Stocks To Own Right Now: SanDisk Corporation(SNDK)

Sandisk Corporation designs, develops, and manufactures NAND flash memory storage solutions that are used in various consumer electronics products. The company offers removable cards under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; embedded products under the iNAND brand; universal serial bus (USB) flash drives under the Cruzer brand; digital media players under the Sansa brand; solid state drives under the Lightning brand; and wafers and memory components. Its removable card products are used in a range of consumer electronics devices, including mobile phones, digital cameras, gaming devices, and laptop computers; and embedded flash products are used in mobile phones, tablets, ultrabooks, eReaders, global positioning system devices, gaming systems, imaging devices, and computing platforms. The company also provides high-capacity storage solutions, such as solid-state drives that are used in lieu of hard disk drives. It offers its products to the m obile phone, consumer electronics, and computing end markets through original equipment manufacturers, distributors, and retail sales channels in the Americas, the Asia Pacific, Europe, the Middle East, Africa, and Japan. The company was formerly known as SunDisk Corporation and changed its name to SanDisk Corporation in August 1995. SanDisk Corporation was founded in 1988 and is headquartered in Milpitas, California.

Advisors' Opinion:

• [By Magic Diligence]

  SanDisk (SNDK) - A Pure Play on FlashSanDisk is one of the only pure plays on flash in the market. SanDisk breaks its sales into two channels. The Retail channel is flash storage cards/sticks for smartphones, digital cameras, and the like (about 37% of sales). The Commercial channel includes embedded flash solutions for OEM customers and solid state drives, or SSDs, that replace traditional hard drives in newer PCs. SanDisk has moved aggressively into Enterprise SSDs with the purchase of SMART Storage Systems a few months ago. SSDs now represent about 20% of revenues, from just 10% a year ago.

• [By Monica Gerson]

  Analysts at Bank of America downgraded SanDisk (NASDAQ: SNDK) from ��uy��to ��eutral.��The target price for SanDisk is set to $75.

  SanDisk's shares closed at $70.80 yesterday.

• [By Rich Smith]

  This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, as earnings season gets under way in earnest, analysts are busy tweaking their price targets to track changes in earnings and guidance. We'll be taking a look at three such tweaks today, for popular stocks: SanDisk (NASDAQ: SNDK  ) , Johnson & Johnson (NYSE: JNJ  ) , and HollyFrontier (NYSE: HFC  ) .

• [By Rich Smith]

  SanDisk is no flash in the pan
  Tuesday dawned bright for owners of "flash" memory specialist SanDisk (NASDAQ: SNDK  ) . The company just announced it will begin selling the "world's fastest 64GB microSDXC card," the SanDisk Extreme microSDXC, which the company says is ideal for use in the latest smartphones, tablets and cameras. No sooner had it done so than analysts at Needham & Co. upped their price target on SanDisk stock to $75 -- a five-buck bump over the previous target.